ARVN vs. ANIX
ARVN (Arvinas, Inc.) and ANIX (Anixa Biosciences, Inc.) are both stocks. Both are in the Healthcare sector — ARVN in Biotechnology, ANIX in Diagnostics & Research. Over the past 5 years, ARVN returned -36.29%/yr vs -6.91%/yr for ANIX. At a 0.21 correlation, their price movements are largely independent.
Performance
ARVN vs. ANIX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARVN achieves a -32.55% return, which is significantly lower than ANIX's -10.58% return.
ARVN
- 1D
- -0.37%
- 1M
- -9.60%
- YTD
- -32.55%
- 6M
- -34.21%
- 1Y
- 2.56%
- 3Y*
- -33.34%
- 5Y*
- -36.29%
- 10Y*
- —
ANIX
- 1D
- 6.49%
- 1M
- 5.28%
- YTD
- -10.58%
- 6M
- -12.81%
- 1Y
- -17.46%
- 3Y*
- -3.86%
- 5Y*
- -6.91%
- 10Y*
- -0.76%
ARVN vs. ANIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
ARVN Arvinas, Inc. | -32.55% | -38.13% | -53.43% | 20.32% | -58.35% | -3.29% | 106.69% | 219.77% | -38.81% |
ANIX Anixa Biosciences, Inc. | -10.58% | 34.48% | -40.21% | -8.71% | 43.10% | -3.26% | -6.40% | -16.75% | -18.09% |
Correlation
The correlation between ARVN and ANIX is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.31 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Sep 27, 2018 | 0.21 |
The correlation between ARVN and ANIX shifts across timeframes, from 0.21 (all time) to 0.31 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
ARVN:
$512.00M
ANIX:
$93.72M
ARVN:
-$3.22
ANIX:
-$0.23
ARVN:
1.32
ANIX:
6.47
ARVN:
$89.40M
ANIX:
$0.00
ARVN:
$72.60M
ANIX:
-$19.00K
ARVN:
-$233.90M
ANIX:
-$10.68M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARVN vs. ANIX — Risk / Return Rank
ARVN
ANIX
ARVN vs. ANIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Arvinas, Inc. (ARVN) and Anixa Biosciences, Inc. (ANIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ARVN | ANIX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.29 | ||
| Sortino ratioReturn per unit of downside risk | +0.36 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.01 | +0.04 |
| Calmar ratioReturn relative to maximum drawdown | 0.05 | -0.32 | +0.37 |
| Martin ratioReturn relative to average drawdown | 0.14 | -0.53 | +0.67 |
Loading charts...
Drawdowns
ARVN vs. ANIX - Drawdown Comparison
The maximum ARVN drawdown since its inception was -94.37%, roughly equal to the maximum ANIX drawdown of -98.74%. Use the drawdown chart below to compare losses from any high point for ARVN and ANIX.
Loading charts...
Drawdown Indicators
| ARVN | ANIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.37% | -98.74% | +4.37% |
Max Drawdown (1Y)Largest decline over 1 year | -49.53% | -54.98% | +5.45% |
Max Drawdown (3Y)Largest decline over 3 years | -88.40% | -57.57% | -30.83% |
Max Drawdown (5Y)Largest decline over 5 years | -94.37% | -65.37% | -29.00% |
Max Drawdown (10Y)Largest decline over 10 years | — | -91.11% | — |
Current DrawdownCurrent decline from peak | -92.58% | -94.13% | +1.55% |
Average DrawdownAverage peak-to-trough decline | -52.21% | -77.40% | +25.19% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.47% | 33.22% | -14.75% |
Volatility
ARVN vs. ANIX - Volatility Comparison
The current volatility for Arvinas, Inc. (ARVN) is 14.96%, while Anixa Biosciences, Inc. (ANIX) has a volatility of 17.86%. This indicates that ARVN experiences smaller price fluctuations and is considered to be less risky than ANIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARVN | ANIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.96% | 17.86% | -2.90% |
Volatility (6M)Calculated over the trailing 6-month period | 36.47% | 35.67% | +0.80% |
Volatility (1Y)Calculated over the trailing 1-year period | 56.21% | 70.58% | -14.37% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 68.86% | 71.15% | -2.29% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 78.01% | 93.67% | -15.66% |
Dividends
ARVN vs. ANIX - Dividend Comparison
Neither ARVN nor ANIX has paid dividends to shareholders.
Financials
ARVN vs. ANIX - Financials Comparison
This section allows you to compare key financial metrics between Arvinas, Inc. and Anixa Biosciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ARVN and ANIX have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ANIX has higher volatility (17.86%) compared to ARVN (14.96%). In terms of maximum drawdown, ARVN dropped -94.37% vs ANIX's -98.74%.
ARVN currently has the higher Sharpe Ratio (0.05 vs -0.25), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARVN and ANIX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer